Interventional radiology market seen reaching $54.31 billion by 2030

The Business Research Company says the global interventional radiology market will rise from $29.98 billion in 2025 to $54.31 billion by 2030, driven by cancer cases, imaging advances and demand for minimally invasive care. North America led the market in 2025, while Asia-Pacific is projected to grow fastest.

Why it matters: - The interventional radiology market is expanding as hospitals and providers adopt image-guided, minimally invasive procedures that can reduce discomfort and recovery time. - The market outlook points to rising demand for tools and training tied to cancer care, cardiovascular treatment and outpatient procedures. - The report's forecast signals continued investment in advanced imaging equipment and hybrid operating room setups through 2030.

What happened: - The Business Research Company projected the interventional radiology market will grow from $29.98 billion in 2025 to $33.94 billion in 2026. - The market is forecast to reach $54.31 billion by 2030. - The company said the 2026-2030 period implies a 12.5% CAGR. - The market's 2025-2026 growth rate is projected at 13.2% CAGR. - The report was released from London on Aug. 12, 2026. - A free sample report is available here. - The full market report is available here.

The details: - Interventional radiology uses imaging technology to guide minimally invasive procedures for diagnosis and treatment. - The field is used for vascular blockages, tumors and other conditions. - The report cited growth drivers including chronic vascular disease, broader adoption of minimally invasive treatments, expansion of hospital imaging facilities, more catheter-based interventions and better diagnostic imaging technology. - Future growth is linked to demand for precision oncology procedures, more investment in sophisticated imaging equipment, wider access to training programs, preference for image-guided therapies and a shift toward outpatient procedures. - The report highlighted trends including wider acceptance of image-guided minimally invasive techniques, deeper integration of advanced imaging methods, more precision-based therapies, growth in hybrid operating rooms and a stronger focus on procedure accuracy and patient outcomes. - The report said interventional radiology can offer reduced patient discomfort and shorter recovery times than traditional surgery. - In 2025, North America held the largest share of the global market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Cancer burden is a central demand driver for the market because interventional radiology techniques such as ablation, embolization and irreversible electroporation are used in cancer and cardiovascular treatment. - Cancer diagnoses in Australia rose from 160,570 in 2022 to 164,694 in 2023, according to the Australian Institute of Health and Welfare. - The regional outlook suggests mature markets remain dominant now, but faster growth is shifting toward Asia-Pacific as healthcare systems expand imaging capacity and procedural adoption. - The report's emphasis on TAM analysis, scoring tools and forecasting dashboards suggests the market is being positioned for strategic planning by suppliers and investors.

What's next: - The Business Research Company expects continued market expansion through 2030 as outpatient use, precision oncology and image-guided care gain ground. - The company said future reports will include deeper market intelligence, market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspots infographics. - The company also listed contact information for expert discussions and sales follow-up.

The bottom line: - Interventional radiology is moving from a specialty segment into a larger growth market, powered by cancer care demand, imaging innovation and the shift to less invasive procedures.